ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Stemline Therapeutics Inc.

NEW YORK, May 4, 2020 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Stemline Therapeutics, Inc. (NASDAQ: STML) and its board of directors concerning the proposed acquisition of the company by Menarini Group. Stockholders will receive $11.50 and one contingent value right of $1.00 for each share of Stemline Therapeutics stock that they hold. The transaction is valued at approximately $677 million and is expected to close in the second quarter of 2020.

If you are a stockholder of Stemline Therapeutics Inc. and are interested in obtaining additional information regarding this investigation, please visit us at:
http://www.rowleylawpllc.com/investigation/stml. You may also contact Shane Rowley, Esq. at Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at info@rowleylawpllc.com, or by telephone at 914-400-1920 or 844-400-4643 (toll-free).  

Rowley Law PLLC represents shareholders nationwide in class actions and derivative lawsuits in complex corporate litigation. For more information about the firm and its attorneys, please visit http://www.rowleylawpllc.com. 

Attorney Advertising. Prior results do not guarantee a similar outcome.

View original content:http://www.prnewswire.com/news-releases/alert-rowley-law-pllc-is-investigating-proposed-acquisition-of-stemline-therapeutics-inc-301052004.html

SOURCE Rowley Law PLLC